Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

InDevR
2100 Central Ave, Suite 106
Boulder, CO 80301
Phone: 303-402-9100
https://indevr.com

InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. With a strong history of non-dilutive funding raises, including a $14.7M BARDA contract to develop a high information content influenza diagnostic and recent investment from the Bill & Melinda Gates Foundation to advance measles and rubella vaccine characterization, InDevR has launched several successful life science tool-based product lines including VaxArray and Cypher One.

Key Contact
Name
Dr. Kathy Rowlen
Title
CEO & Co-Founder
Funding Events

Date
Amount
Type
Investors
Valuation
09/12/19 $7,000,000 Series A Adjuvant Capital
undisclosed